PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.\', \'Department of Genome Sciences & Medical Scientist Training Program, University of Washington, Seattle, Washington, United States of America.\', \'Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.\', \'Africa Health Research Institute, Durban, South Africa.\', \'School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.\', \'Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.\', \'Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America.\', \'Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1010248
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 35134084
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all